Product image of Naropin (Ropivacaine Hydrochloride) supplied by GNH India

Naropin

Active Ingredient:
Ropivacaine Hydrochloride
Origin:
EU

Naropin (Ropivacaine Hydrochloride)

Ropivacaine Hydrochloride, the active ingredient in Naropin, is a local anesthetic (amide) presented as a sterile solution for infiltration and intrathecal use. It provides regional anesthesia for surgical procedures, epidural or spinal analgesia, and peripheral nerve blocks.
GNH India supplies Naropin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Aspen Pharma Trading Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ropivacaine is used in the field of regional anesthesia and analgesia, acting on peripheral nerves to block pain transmission.

  • Surgical anesthesia: provides local anesthesia for a variety of surgical procedures.
  • Epidural or spinal analgesia: delivers analgesia for labor, cesarean sections, or postoperative pain control.
  • Peripheral nerve block: facilitates targeted nerve block for postoperative pain management.
  • Postoperative analgesia: extends pain relief after surgery, reducing opioid requirements.

How It Works

  • Ropivacaine reversibly blocks voltage‑gated sodium channels on neuronal membranes, preventing the initiation and propagation of nerve impulses. By stabilizing the neuronal membrane, it inhibits depolarization and thus interrupts pain signal transmission in the targeted area.

Side Effects

Ropivacaine may cause a range of adverse reactions, most of which are related to its local anesthetic properties.

Common Side Effects

  • Injection site pain: discomfort at the site of administration.
  • Hypotension: transient drop in blood pressure.
  • Bradycardia: slower than normal heart rate.
  • Nausea: feeling of sickness or urge to vomit.
  • Dizziness: light‑headed sensation.
  • Tingling or numbness: transient sensory changes.

Serious or Rare Side Effects

  • Seizure: central nervous system excitation.
  • Cardiac arrest: severe cardiac depression.
  • Allergic reaction (anaphylaxis): potentially life‑threatening hypersensitivity.
  • Respiratory depression: reduced breathing effort.
  • Persistent neurologic deficit: prolonged sensory or motor block.
  • Methemoglobinemia: abnormal hemoglobin affecting oxygen transport.

Precautions & Warnings

When using Ropivacaine, clinicians should observe several safety measures.

  • Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics.
  • Cardiovascular status: monitor patients with existing cardiac disease or conduction abnormalities.
  • Dosage limits: adhere to recommended maximum doses to avoid systemic toxicity.
  • Concurrent CNS depressants: use caution with agents that may enhance central nervous system effects.
  • Pregnancy: evaluate risk‑benefit ratio before administration.
  • Store at ambient temperature: keep in original container, protect from light and moisture.

Avoid Interactions

Ropivacaine can interact with other medications, altering its safety profile.

Major Interactions (Avoid)

  • Class I antiarrhythmic agents (e.g., quinidine, procainamide): may increase cardiotoxicity.
  • Beta‑adrenergic blockers: can potentiate bradycardia and hypotension.

Moderate Interactions (Monitor Closely)

  • Other local anesthetics: additive toxicity risk.
  • CNS depressants (e.g., opioids, benzodiazepines): enhanced sedation or respiratory depression.
  • Lithium: may increase neurotoxic effects.

Frequently Asked Questions

Naropin, containing ropivacaine hydrochloride, is used to provide regional anesthesia and analgesia. It is administered for surgical anesthesia, epidural or spinal analgesia during labor or surgery, and peripheral nerve blocks to manage postoperative pain.

Ropivacaine works by reversibly blocking voltage‑gated sodium channels on neuronal membranes. This inhibition prevents the initiation and propagation of nerve impulses, thereby stopping pain signals from reaching the central nervous system in the area where it is administered.

The dose of Naropin is determined by the prescribing clinician based on the specific procedure, patient characteristics, and route of administration. Only a qualified healthcare professional should set the appropriate dosage and concentration.

Safety of ropivacaine in pregnancy or lactation has not been definitively established. Clinicians should weigh potential benefits against risks and consider alternative options when treating pregnant or breastfeeding patients.

To order Naropin, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Ropivacaine offers a longer duration of sensory block with less motor impairment compared with bupivacaine, and it has a lower risk of cardiotoxicity than some other amide anesthetics. Its pharmacologic profile makes it suitable for procedures requiring prolonged analgesia.

Naropin should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the solution from direct light, moisture, and freezing. Follow standard aseptic handling procedures when preparing for injection.

Naropin is administered by a qualified healthcare professional via infiltration, epidural, spinal (intrathecal), or peripheral nerve block techniques. The specific route and technique depend on the clinical indication and the area requiring anesthesia.

Serious risks include systemic toxicity such as seizures, cardiac arrhythmias, cardiac arrest, and severe allergic reactions (anaphylaxis). Prompt recognition and management of these events are essential, and monitoring should be performed during and after administration.

Naropin should be avoided in patients with known hypersensitivity to amide‑type local anesthetics, those with severe cardiac conduction disorders, or individuals where the risk of systemic toxicity outweighs the benefit. Clinicians must assess each patient’s medical history before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ropivacaine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT